为了研究载体介导的RNAi(RNAinterference)技术特异地抑制K-RASAsn12。(K-RAS第12位密码子突变形式为GAT)在胰腺癌细胞中的表达,合成两条编码针对K-RASAsn12。突变特异性短发夹RNA(shorthairpinRNA,shRNA)序列的单链DNA,并将其克隆到pSilenCircle栽体中,构建含目的基因片段的重组质粒pSC-K-RASAsn12。同法构建含GFP基因片断的重组质粒pSC-GFP做为对照。用其分别瞬时转染人胰腺癌AsPC-1细胞和BxPC-3细胞后,经半定量RT-PCR和Westernblot检测K-RAS的表达水平。结果表明构建的针对K-RASAsn12的编码突变特异性shRNA的质粒表达载体可特异的抑制胰腺癌细胞的K-RASAsn12。表达,但对野生型的K-RAS(K-RASwT)表达无影响。
To silence the expression of K-RASAsn12 in human pancreatic cancer cell line by vector-based RNAi(RNA interference) technique, two single-strand DNA sequences encoding mutant-specific shRNA (short haipin RNA) for K-RASAsn12 were synthesized and then inserted into pSilenCircle. The recombinant plasmid was called pSC-K-RASAsn12. According to the same method, pSC-GFP encoding shRNA for GFP was gained. Both recombinant plasmids were transfected into human pacreatic cancer cell line AsPC-1 and BxPC-3. The expression level of K-RASAsn12 was detected by semi-quantitative RT-PCR and Western blot. The result indicated that the recombinant plasmid edcoding mutant-specific shRNA for K-RASAsn12 can inhibit significantly the expression of K- RASAsn12, without affection of wild-type K-RAS(K-RASWT) in Human Pancreatic Cancer Cell Line.